Johnson SB et al., 2018-01-01: National Cancer Database study of 281 patients with nonmetastatic breast, prostate, lung or colorectal cancer who chose alternative medicine as sole anticancer treatment, matched 2:1 to patients receiving conventional treatment. Alternative medicine was associated with a 2.5-fold greater risk of death overall.
AM use was independently associated with greater risk of death compared with CCT overall (hazard ratio [HR] = 2.50, 95% confidence interval [CI] = 1.88 to 3.27)
p.121 (Abstract)
Johnson SB et al., 2018-01-01: National Cancer Database study of 281 patients with nonmetastatic breast, prostate, lung or colorectal cancer who chose alternative medicine as sole anticancer treatment, matched 2:1 to patients receiving conventional treatment. Alternative medicine was associated with a 2.5-fold greater risk of death overall. Yale authors; the NCDB is maintained by the American College of Surgeons and the American Cancer Society; no industry funder disclosed in the record. Comparator: conventional treatment (surgery, radiotherapy, chemotherapy and/or hormone therapy), matched – not placebo. Method caveats the book can use: AM is defined by the registry code 'Other-Unproven: Cancer treatments administered by nonmedical personnel', which captures refusal of conventional care and does not record what the alternative treatment was; retrospective registry data, no randomisation. Study type: controlled study.
